NUCKS nuclear elevated expression indicates progression and prognosis of ovarian cancer
Open Access
- 7 September 2017
- journal article
- research article
- Published by IOS Press in Tumor Biology
- Vol. 39 (9)
- https://doi.org/10.1177/1010428317714631
Abstract
NUCKS (nuclear, casein kinase, and cyclin-dependent kinase substrate) is implicated in the tumorigenesis of several human malignancies, but its role in ovarian cancer remains unknown. We aim to investigate NUCKS expression and its clinical significance in ovarian cancer. The messenger RNA expression of NUCKS was determined in normal and malignant ovarian tissues using quantitative polymerase chain reaction assay. Immunohistochemistry was applied to detect the status of NUCKS protein expression in 121 ovarian cancer tissues. NUCKS protein high expression was detected in 52 (43.0%) of 121 patients. NUCKS messenger RNA expression was gradually upregulated in non-metastatic ovarian cancers ( n = 20), metastatic ovarian cancers ( n = 20), and its matched metastatic lesions ( n = 20) in comparison with that in normal ovarian tissues ( n = 10; p < 0.05). Elevated expression of NUCKS in ovarian cancer was associated significantly with the Federation of Gynecology and Obstetrics stage ( p = 0.037), histological grade ( p = 0.003), residual disease ( p = 0.013), lymph node metastasis ( p = 0.002), response to chemotherapy ( p < 0.001), and recurrence ( p = 0.013). In the multivariate Cox analysis, NUCKS expression was an independent prognostic marker for overall survival and disease-free survival in ovarian cancer with p values of <0.001 for both. Especially, NUCKS overexpression had prognostic potential for overall survival and disease-free survival ( p < 0.001 for both) in advanced ovarian cancers and only for disease-free survival in early ovarian cancers ( p = 0.017). Our data suggest that NUCKS overexpression may contribute to progression and poor prognosis in ovarian cancer especially in advanced ovarian cancer.Keywords
This publication has 20 references indexed in Scilit:
- Identification of kinases phosphorylating 13 sites in the nuclear, DNA-binding protein NUCKSBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2017
- NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinomaTumor Biology, 2014
- Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinomaTumor Biology, 2014
- Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysisInternational Journal of Cancer, 2012
- Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancerCancer, 2010
- NUCKS overexpression in breast cancerCancer Cell International, 2009
- Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strainsToxicology and Applied Pharmacology, 2008
- Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different speciesBiochemical and Biophysical Research Communications, 2004
- Gene Expression Patterns in Ovarian CarcinomasMolecular Biology of the Cell, 2003
- A novel, highly phosphorylated protein, of the high‐mobility group type, present in a variety of proliferating and non‐proliferating mammalian cellsJBIC Journal of Biological Inorganic Chemistry, 1985